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Edited by Robert Russell and Patrick AloyAbstract Cellular functions are almost always the result of the
coordinated action of several proteins, interacting in protein
complexes, pathways or networks. Progress made in devising
suitable tools for analysis of protein–protein interactions, have
recently made it possible to chart interaction networks on a
large-scale. The aim of this review is to provide a short overview
of the most promising contributions of interaction networks to
human biology, structural biology and human genetics.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Biology relies on the concerted action of a number of bio-
molecules organized in pathways or networks. Molecular biol-
ogists have traditionally studied the interactions and relative
inﬂuence of biomolecules in focused, one at a time studies.
These approaches have contributed insight on limited numbers
of signaling pathways and on the cellular or physiological
functions of proteins.
More recently, advances in high throughput methods make
it possible to study the behavior and attributes of biomolecules
that make up entire systems. This recent interest in whole sys-
tems comes from the belief that systems have functions that
none of the entities of the systems have, and that ‘‘the total
is more that the sum of its parts’’. The rules that govern the
behavior of biological systems are currently the focus of in-
tense research in the ﬁeld of Systems Biology. The resulting
models are expected to be predictive of diﬀerent healthy and
pathological conditions. They might provide synthetic biolo-
gists with the general principles for the (re)engineering of bio-
logical systems for particular purposes [1,2].
In this blooming ﬁeld, systems-wide analyses of protein–pro-
tein interactions have taken center stage. A number of strate-
gies have been applied to the charting of protein–protein
interactions on a large-scale. They include, the yeast two-hy-
brid system [3,4] Aﬃnity Puriﬁcations/Mass Spectrometry
(AP–MS) [5–9] and in silico prediction (reviewed in [10]).
The basic principles behind these approaches as well as their
advantages and limitations have been the subject of extensive
review (for example [10,11]) and will not be discussed here.Corresponding author.
-mail address: gavin@embl.de (A.-C. Gavin).
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doi:10.1016/j.febslet.2008.02.015ieties. PuRather, we will report on the recent applications of these meth-
ods to genome-wide screens.
The ﬁeld is rapidly maturing and the outcomes and pro-
gresses made are clearly visible. Even if the coverage remains
quite low and the resulting networks are usually characterized
by a high rate of false negatives (only about 15% of all pos-
sible interactions have been charted so far [12]), the ﬁrst car-
tographies of several pathways and networks that map
behind main human pathologies have already emerged. In
model systems, global, genome-scale, protein–protein interac-
tion screens have provided a molecular framework for the
interpretation of very simple genetic data, such as gene essen-
tiality [13]. A number of databases have been developed that
integrate standardized biomolecular interaction data from
various origins [14].2. Modality of protein–protein recognition; structures
Proteins inside the cell do not interact randomly. Protein
associations need precise regulation. The spatial and temporal
regulation of enzyme activities through extensive interactions
bears remarkable functional relevance. In human, mutations
or environmental factors that interfere with protein–protein
interaction lead to pathology. This is the case in the Immuno-
deﬁciency, Centromeric instability, Facial anomalies (ICF)
syndrome, caused by defects in DNMT3B, a DNA methyl-
transferase. The missense mutations have been mapped not
only within the catalytic site but also aﬀect an N-terminal
PWWP domain of DNMT3B, involved in protein–protein
interactions [15]. Even discrete changes in the aﬃnities between
two interacting protein pairs can have devastating conse-
quences. For instance, mutations in the Fibroblast Growth
Factor Receptor 2 (FGFR2) that selectively increase the aﬃn-
ity for FGF2 [16] are responsible for the Apert syndrome,
characterized by skull malformation, syndactyly and mental
deﬁciency.
A wide variety of modular and specialized binding domains
have been mapped that mediate protein–protein recognition
[17]. Even though the distinction is not always very strict,
interaction domains are thought to generally operate through
two mechanisms (Fig. 1). Domains sometimes bind other do-
mains. Typically, this type of interactions involves large bind-
ing interfaces provided by the rigid globular domains. This is
illustrated by the interaction taking place between Ras and
its GTPase activating protein Ras-GAP, which play a crucial
role in regulating cellular signal transduction processes [18].
Domain–domain interactions are thus generally characterized
by relatively high stabilities and aﬃnities in the low nM to
pM range [19,20].blished by Elsevier B.V. All rights reserved.
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Fig. 1. Protein interactions usually happen through two rather distinct mechanisms. Protein recognition mediated by domain–domain interaction is
illustrated on the left part of the ﬁgure with the binding of Ras to Ras-GAP (PDB:1wq1). Domain-linear motif interactions are exempliﬁed on the
right with the binding of the proline rich ligand RALPPLPRY to a SH3-domain (PDB: 1RLQ). A few characteristic features of each mode of binding
are also highlighted. Structures are visualized using the program VMD [58].
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typically between 3 and 10 amino acids, present in disordered
parts of proteins (Fig. 1). For example, Src Homology 2 (SH2)
domains speciﬁcally interact with small peptides containing a
phosphotyrosyl residue. PDZ domains can also target small
(4 amino acid long) consensus binding motifs located at the
C-terminus of the interaction partners. These short linear mo-
tifs are critical to many biological processes. They often show
low aﬃnities (0.5–10 lM) [21,22]. They tend to be mediators in
transient interactions, such as the ones seen in cell signaling
[23]. Residues of the linear motif can directly contribute the
totality of the binding energy. But in many cases, additional
indirect induced ﬁt mechanisms are important to stabilize the
interaction [24]. The number of known linear motifs capable
of engaging in an interaction is still relatively small (a few hun-
dreds). They have traditionally escaped the detection by classi-
cal sequence alignment algorithms. The recent availability of
several large interaction networks have open the way to more
systematic approaches for ﬁnding protein linear motifs that
mediate protein–protein interactions [22,25]. These motifs
have recently attracted much attention as targets of small mol-
ecules that disrupt protein–protein interactions (reviewed in
[26,27]).
In the majority of the cases the sequence or the structural
determinants responsible for the speciﬁcity and the precision
of the recognition remain unknown. Methods such as muta-
tion (alanine) scanning, or the monitoring of binding aﬃnities
to peptide libraries have provided and are still providing, very
interesting and valuable information regarding the sequences
involved. Structural determinants are certainly more diﬃcult
to capture. Recent strategies have been developed that aim
at the systematic structural resolution of macromolecular
assemblies. These strategies integrates large datasets on the
biochemical composition of protein complexes with data on
their low-resolution structure by Electron Microscopy (EM)and the X-ray crystallography of individual interacting do-
mains or proteins [28–31]. Ultimately, these eﬀorts may con-
tribute to the resolution of the protein assembly code that
converts the genomes information into a biologically func-
tional third dimension [32,33].3. Interaction networks in diseases
Protein interaction networks reveal the connectivity of a
proteome in a given cellular context. They reﬂect a particular
cellular status. Protein interaction networks are dynamics
and change in time and space to adapt or switch to diﬀerent
physiological conditions. An attractive application is the cap-
turing of the changes in protein connectivity that associate
with progression towards diseases (Fig. 2).
A ﬁeld concerns the study of pathogenic organisms and their
interface with host cells. A growing number of interaction net-
works from many diﬀerent pathogens have been recently pro-
duced. They include several viruses such as the Kaposi
Sarcoma-associated Herpes Virus (KSHV), Varicella-Zoster
Virus (VZV) and Epstein-Barr Virus (EBV) [34,35]. Interest-
ingly, these viral networks appear to possess distinct overall
topologies from the ones of the host cells. Most biological net-
works follow the so called small-world and scale-free behavior,
where only few nodes act as ‘‘highly connected hubs’’ and the
majority of the nodes are of low degree (are engaged in only
few interactions). This attribute is believed to confer resistance
to random attacks but makes scale-free networks extremely
susceptible to targeted perturbations. The viral interaction net-
works do not possess these properties. The current hypothesis
is that viral networks, in the absence of a host, are incomplete.
Consistent with this view is the observation that upon docking
on the cellular network, the viral networks assimilates the
properties of the host one [34,35]. As they become more com-
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Fig. 2. Protein interaction networks from diﬀerent cellular status. Diﬀerent networks illustrative of diﬀerent cellular conditions are represented as
graph on the top part of the ﬁgure. The light green lines represents weak interaction, dark green lines are strong ones. Red circles illustrate proteins
that are not present in all networks and red halos highlight the changed part of the interactome. The heat map depicts the interactions happening in
each cellular state. Boxes are colour-coded according to the strength of the interaction.
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a broader view on how viruses use the cellular machinery to
their own purpose. New opportunities for small molecule
inhibitors may emerge.
More challenging approaches concerns the charting of the
dynamics changes happening during progression towards var-
ious diseases status. The analyses have been traditionally lim-
ited by the intrinsic diﬃculties in charting the dynamics
properties of protein–protein interactions on a large-scale (re-
viewed in [36]). Many of the currently used approaches for the
analysis of protein–protein interactions imply the expression of
proteins under non-physiological conditions (for example in ex
vitro systems, such as yeast two-hybrids) or in non-synchro-
nized, heterogeneous populations of cells (for example for bio-
chemical approaches such as AP–MS). The spatial and
temporal regulations are usually lost.
Early attempts to ﬁll this gap come from studies in a model
organism, Saccharomyces cerevisiae. The dynamics of interac-
tions was captured by the superimposition of the temporal
changes in gene expression that associate with diﬀerent cellular
conditions on static protein interaction networks [37–39]. Re-
cently, these approaches have been applied in human to the
modeling of aging [40] or drug addiction [41]. An aging inter-
action network was built by the integration of the transcrip-
tional changes observed in tissues derived from young and
old humans with protein–protein interaction networks. Inter-
estingly, genes that are diﬀerentially expressed during agingseem to often represent key regulatory nodes, probably impor-
tant for overall network stability [40].4. Interaction networks as molecular frame for genetic data
Proteins often serve more than one cellular function. One
manifestation of this so called pleiotropy is the observation
that diﬀerent mutations in a single gene cause multiple, signif-
icantly diﬀerent phenotypes [42]. Molecular mechanisms, such
as alternative splicing and post-translational modiﬁcations,
probably account for pleiotropy. Gene pleiotropy might also
rely on the tendency of proteins to associate with diﬀerent
partners in diﬀerent cellular contexts and, as a result, exert di-
verse functions [43]. In human, good illustrations are muta-
tions in the Xeroderma Pigmentosum group D-
complementing protein (XPD) gene that cause diseases with
diﬀerent symptoms: Xeroderma Pigmentosum (XP) or Tricho-
ThioDystrophy (TTD). XPD is a subunit of the TFIIH basal
transcription factor complex implicated in both transcriptional
regulation and DNA repair through the selective recruitment
of speciﬁc factors [44]. The current hypothesis is that diﬀerent
mutations in XPD aﬀect either the DNA repair function of
TFIIH (XP results) or its transcriptional role (TTD results)
[45]. More generally, the degree of connectivity of a protein
positively correlates with the number of traits it inﬂuences or
its degree of pleiotropy [46].
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that almost 40% of the proteins are part to more than one pro-
tein complex [47]. This raised the view that protein multifunc-
tionality may be a more general attribute than anticipated. In
higher eukaryotes, interaction networks may not only provide
a molecular frame for the explanation of genetic traits, like
pleiotropy, but are also expected to contribute to the selection
of more speciﬁc and ‘‘safer’’ drug targets.
It is also relatively common that mutations in diﬀerent genes
sometimes lead to similar or related phenotypes. Generally it is
assumed that this reﬂects disruptions in proteins that partici-
pate in a common interaction network, such as the diﬀerent
subunits of a multiprotein complex or proteins that function
at diﬀerent steps of a signaling or biochemical pathway [48].
In human, a striking example is provided by the nine genes
associated with the Fanconi Anaemia (FA) syndrome that
cooperate in a common network, the FA/BRCA2 (Breast Can-
cer type 2) pathway involved in DNA repair. Noticeably, seven
of the FA proteins form a multiprotein complex [49]. More
broadly, interaction networks help identify genes with similar
phenotypes [7,50]. For example, Lim et al. recently report an
interaction network for human inherited ataxias that intercon-
nect the majority of the ataxia-causing proteins and some
modiﬁer of neurodegeneration in animal models [51]. The
ataxia interactome reveals common cellular pathways that
might cause Purkinje cell dysfunction. It also provides an inter-
esting tool for identifying new genes for inherited ataxias. The
use of interaction networks to prioritize positional candidate
disease genes identiﬁed by linkage or association studies is very
promising approach that becomes more and more popular [52–
54]. The most recent developments concern the integration of
human phenotypes with protein interaction data to built a hu-
man phenome-interactome network [55]. More than 500 pro-
tein complexes associated with human genetic syndromes
were deduced that were used to predict novel gene candidates
for about 800 intervals linked to diseases.5. Conclusion
After about a decade of intensive screening for protein inter-
action in various organisms, the eﬀorts start to pay back. We
witness a blooming number of publications reporting on the
application of interactome network to human biology
[56,57], structural biology [29] and human genetics [55]. These
advances are linked to the recent availability of high quality
interactomes maps. Despite this spectacular (encouraging)
progress the road is still long until we achieve a comprehensive
view on interaction networks. The available maps are still
scanty and still suﬀer from a high rate of false negatives. Also,
typically, they remain static and lack essential information
capturing the logic of the molecular networks. They do not
‘‘qualify’’ the types of relationships between the various com-
ponents. Because of their functional relevance, it is very likely
that in the future interactions themselves (and not only the
proteins involved) will deserve functional or spatial annota-
tion.
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